I think you meant to say Abbive and not Amgen since that is an Abbvie/Gilead fight in that space. Again, the conversion will not happen overnight. Gilead is not knocked out all together just second to Abbvie. Who knows how long GILD will let this situation stand. If it really doesn't hurt them maybe they hold pat. BUT the big DIFFERENCE here is that is an established market, one where ESI has to face facts and be realistic in what they can actually effect. The PCSK9 will be different. ESI and the others will pick one first line, one step edit second line and will be able to enforce this from Day 1. Whoever loses this/these contracts will automatically be relegated to second fiddle. I can't say/put it any clearer. Let's see what happens. I am not an "I told you so" person. In fact, I hate that. Moreover, as a shareholder of both companies, I am trying to make a decision on what to do. Both could win, both could lose, both could split decision (among the 3). My instinct here is to hold AMGN and sell REGN. I am long both stocks. (I still own AMGN shares from when I worked there in the late 80s/early 90s). Likewise, I have been in REGN for 4 years so I am way up there too. I just see more downside for REGN shares if they lose one or more of these contracts since the stock is trading at nearly 150X earnings vs AMGNs' roughly 22X. Great chatting with you though, even if you called me a f'ing idiot. Have a great weekend
